• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic
  • Guestorial: Demand for Nationalization of Healthcare Services in India
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea
  • Phablecare Raises ₹187 Cr In Funding
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News – India
    • BioMedical
    • BioBusiness
    • BioResearch
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
    • Biotech Express Issues – Access Page
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Omicron is attenuating COVID-19, Says Prominent Virologist Prof Ramareddy Guntaka

Omicron is attenuating COVID-19, Says Prominent Virologist Prof Ramareddy Guntaka

0
By Biotech Express on January 24, 2022 Articles, Articles- Editorials, SARS- CoV2 & COVID-19 Updates

In an interview by Eenadu TV recently I mentioned that although Omicron infections go up, its effect on causing serious disease and death is minimal. Now I confidently say that even though it infects the vaccinated people, it is very feeble. This is already seen in US and other European countries. For example, this week the average number of Covid cases in the US is about 600,000 to 700,000 and the average deaths are about 1400-1600. A vast majority of these are due to Covid 19 or Delta variant, not due to Omicron. This translates to about 1 death for 400 to 500 positive cases compared to about 1 death per 50 to 60 infected people in the earlier periods during April-May and during July-August 2021 (See the Table).

Clearly it indicates that most of deaths are due to original Covid-19 and Delta variant and the Omicron does not cause severe disease and death. Since many of the vaccinated people are getting infected with Omicron, it would indicate that the mRNA vaccine induced antibodies are not effective in neutralizing Omicron.

It is also possible that the Omicron’s tropism has changed. Likely, Omicron is infecting upper respiratory cells than deep alveolar epithelial cells. It has been shown that there are as many as 40 to 50 mutations in the Spike protein alone, compared to only 7 to 8 mutations in the Delta variant. Therefore, it is reasonable to assume that these mutations altered the virus pathogenicity. In essence Omicron is attenuated.

The cases in India are also increasing but the death rate is drastically reduced (See Table), suggesting that the variant Omicron is weakened, largely due to many mutations in the Spike Protein and elsewhere in the viral genome. This means that Omicron does not cause more than a mild disease, with symptoms like the Human Coronaviruses 229E and OC43, which cause seasonal colds and upper respiratory infection. From these data I conclude that Covid-19 is on its way out. This is due to the vast number of mutations which crippled the virus or attenuated.

No doubt that Omicron is transmitting much faster than Covid-19 or Delta variant. Yet it is causing much milder disease, indicating that in each cycle the infected cells are producing a smaller number of infectious virus and more defective particles. In general, this particular variant has much higher mutation rate, probably due to defective proof reading function of the virus. For example, the exonuclease encoded by the Coronavirus removes any mutated nucleotides that are incorporated into the genome during replication; if this gene is also mutated then the proof reading or editing function is affected resulting in accumulation of mutations. These mutant viruses behave differently than the parent virus and are attenuated.

Cautious note about RT-PCR Tests to detect Omicron:
Since the existing Covid tests do not clearly distinguish Omicron from Delta or Covid 19, is it worth doing these tests anymore? This will add only the number of new cases which are no doubt rising in every country. Under these circumstances it might be prudent to rely on the symptoms rather than the Spot or PCR test. Assume a person is infected with Omicron, virus replicates and in a day or two he or she will be positive for the virus and symptoms appear most likely on 2nd or 3rdday after infection. If the symptoms are mild for another 3 days and subside with running nose and mild cough persisting, then we can safely assume it is not serious. On the other hand, if the patient gets worse with severe cough and experiencing breathing problems, then he or she can be tested and hospitalized, if necessary.

In USA, it appears that many hospitalized patients are kept for a period of 2 to 3 days, unless they need intensive care treatment. Even this also is not on the magnitude with other COVID-19 or Delta variant. If they keep doing these tests naturally the numbers go up enormously, which make people panicked as is happening now. If a specific and sensitive test is developed for Omicron, then we would know that it doesn’t cause any serious disease and therefore, people will feel much better.

Conclusions:
Since Omicron does not cause serious illness, people should not get panicked and rush to getting tested.
The tests presently available do not distinguish Omicron from Delta or Covid-19, people should consider getting tested if they are experiencing severe symptoms.
Omicron symptoms are very similar to the symptoms produced by other forms of Coronaviruses, which cause only mild upper respiratory symptoms.
Thanks to Coronavirus imposed masks, the flu cases have significantly reduced in both 2020 and 2021 seasons and the deaths associated with flu also drastically reduced.

About the Prof Ramareddy V Guntaka
Professor Guntaka is Emeritus Professor in Department of Microbiology, Immunology & Biochemistry, University of Tennessee, Health Sciences Center, Memphis, TN, USA and Chairman and Chief Scientist at Sudarshan Biotech Pvt Ltd., India.
• Prof Guntaka was one of the four members team that discovered Proto-oncogenes, genes implicated in causing cancer.
• Prof Guntaka was the first one to molecularly clone the entire genome of Rous Sarcoma Virus
• Prof Guntaka was the key scientist behind the successful development of the Recombinant Hepatitis B Vaccine.by Shantha Biotech
• Prof Guntaka was also the key scientist behind the successful development of interferon alpha used to treat hepatitis B infections.
• Prof Guntaka was also the first scientist to clone and study the complete genome of the Indian strains of Hepatitis C virus

Read more about Prof Guntaka here: http://www.biotechexpressmag.com/wp-content/uploads/2019/11/Interview-Prof-Ramareddu-V-Guntaka.pdf

 

Full Article for Subscribers Only!

 

 

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports

Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic

Guestorial: Demand for Nationalization of Healthcare Services in India

Leave A Reply Cancel Reply

Current Issue – April 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Editorial: What serious side effects reported after inoculation of Indian COVID-19 vaccines: Survey of AEFI reports April 25, 2022
  • COVID-19 scientists are facing an avalanche of abuse, Science survey shows April 24, 2022
  • Editorial: Plastic found in human blood – Call an urgency to switch to bioplastic April 24, 2022
  • Guestorial: Demand for Nationalization of Healthcare Services in India April 24, 2022
  • 19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre’s Response On Parents’ Plea April 15, 2022
  • Phablecare Raises ₹187 Cr In Funding April 11, 2022
  • Pfizer Hired 1,800 Additional Employees In 2021 To Process Huge Increase In Vaccine Adverse Events April 9, 2022
  • Experts write to PM against WTO proposal on COVID-19 vaccine waivers April 8, 2022
  • Bose Institute Scientists earn retraction due to manipulation April 5, 2022
  • WHO suspends Covaxin supply to UN agencies April 4, 2022
  • Lockdowns, Not the Pandemic, Created Havoc April 1, 2022
  • WHO selects Biological E to transfer mRNA COVID vaccine tech April 1, 2022
  • Dr. Reddy’s Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in Germany April 1, 2022
  • New Zealand High Court ENDS Vaccine Mandate: “It’s a Gross Violation of Human Rights” April 1, 2022
  • S&T Ministry to support startup in medical implants March 31, 2022
  • FDA Clears Marketing of Genome-Edited Beef Cattle March 30, 2022
  • Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey March 30, 2022
  • Undisclosed industry payments rampant in drug-trial papers in Australia March 29, 2022
  • Fraud Trial of Former Theranos Executive Ramesh’ Sunny’ Balwani Begins March 29, 2022
  • Substandard, fake medical products increased by almost 47% from 2020 to 2021 during pandemic: report March 29, 2022
  • Editorial: Biofuels in India – a perfect waste to wealth and net zero emission energy option March 29, 2022
  • Bharat Biotech and BIOFABRI partner to develop, manufacture and distribute novel TB vaccine March 28, 2022
  • Fibroheal raises debt funding from BIRAC March 28, 2022
  • Editorial – Energy, Renewable Energy and Bioenergy March 28, 2022
  • IISc, India to set up public health centre with Rs105 cr funding from philanthropist March 27, 2022
  • Tamil Nadu makes scientifically dubious claim on vaccines in the Supreme Court March 27, 2022
  • Guest Article: GENE EDITED-CRISPERED FLOWERS: Blooming with grace March 27, 2022
  • Dr. Anthony Fauci, Biden admin operated with missing data as CDC issued pandemic guidance, emails show March 25, 2022
  • Contents – February 2022 March 3, 2022
  • Drs Ella deserve Padma Award for their innovations and management in biotechnology: India’s pioneer recombinant biologist Prof Ramareddy Guntaka February 26, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • Articles- News Reports
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • BioResearch – Industry
  • Biotech – Agriculture
  • Biotech – Healthcare
  • Biotech – Supplies
  • Biotech News – Featured
  • Biotech News – India
  • Biotech News – Industry
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.